一分钟看懂
这是一项关于胰腺癌的III 期研究，登记的药物或干预包括XNW28012 for injection；XNW28012 Mimetic for Injection，当前状态为招募中。登记地点显示中国上海、北京、滨州、长沙等城市有研究中心记录。是否仍有名额以及是否值得进一步询问，需要向研究中心确认。
药物或干预
XNW28012 for injection；XNW28012 Mimetic for Injection · III 期
中国哪些地方有记录
以下地点来自登记信息，不代表此刻仍有名额；请向研究中心确认最新情况。
- Fudan University Cancer Hospital · 上海
- Beijing Friendship Hospital, Capital Medical University · 北京
- Beijing Tsinghua Changgung Hospital · 北京
- Peking Union Medical College Hospital, Chinese Academy of Medical Sciences · 北京
- Affiliated Hospital of Binzhou Medical College · 滨州
- Hunan Cancer Hospital · 长沙
- The First People's Hospital of Changzhou · 常州
- Sichuan Provincial People's Hospital · 成都
- West China Hospital, Sichuan University · 成都
- Chongqing University Cancer Hospital · 重庆
- Fuyang Cancer Hospital · 阜阳
- Fujian Cancer Hospital · 福州
- Union Hospital Affiliated to Fujian Medical University · 福州
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University · 广州
- Sir Run Run Shaw Hospital, Zhejiang University School of Medicine · 杭州
- Zhejiang Cancer Hospital · 杭州
- Harbin Medical University Cancer Hospital · 哈尔滨
- Anhui Provincial Cancer Hospital · 合肥
- The First Hospital of Jilin University · 吉林市
- Cancer Hospital Affiliated to Shandong First Medical University · 济南
- Jinan Central Hospital · 济南
- Gansu Provincial Cancer Hospital · 兰州
- Meizhou People's Hospital · 梅州
- Jiangxi Provincial Cancer Hospital · 南昌
- The First Affiliated Hospital of Nanchang University · 南昌
- Jiangsu Cancer Hospital · 南京
- Jiangsu Provincial People's Hospital · 南京
- Nanjing Drum Tower Hospital Affiliated to Medical School of Nanjing University · 南京
- Tumor Hospital Affiliated to Guangxi Medical University · 南宁
- Peking University Cancer Hospital Inner Mongolia Hospital · 内蒙古自治区
- People's Hospital Affiliated to Ningbo University · 宁波
- Shanghai East Hospital · 上海
- Shanghai Fourth People's Hospital · 上海
- Zhongshan Hospital, Fudan University · 上海
- Liaoning Cancer Hospital · 沈阳
- The First Affiliated Hospital of China Medical University · 沈阳
- Shanxi Cancer Hospital · 太原
- The First Hospital of Shanxi Medical University · 太原
- Tianjin Cancer Hospital · 天津
- Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology · 武汉
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · 武汉
- The Second Affiliated Hospital of Xi 'an Jiaotong University · 西安
- Xiamen Hospital of Traditional Chinese Medicine · 厦门
- Xiangyang Central Hospital · 襄阳
- Northern Jiangsu People's Hospital · 扬州
- General Hospital of Ningxia Medical University · 银川
- Henan Cancer Hospital · 郑州
- The First Affiliated Hospital of Zhengzhou University · 郑州
公开的入选条件
- * Metastatic pancreatic ductal adenocarcinoma (PDAC), including adenosquamous carcinoma, confirmed histologically or cytologically.
- * Disease progression or toxicity intolerance after receiving two previous standard therapies (gemcitabine and fluorouracil-based chemotherapy).
- * Men and women were 18 years of age or older at the time of informed consent. At least one measurable lesion met RECIST 1.1 criteria. The region should have received no previous local treatment, such as radiotherapy, or there should be evidence of definite pr
- * Eastern Cooperative Oncology Group (ECOG) performance status 0-2.
- * Subjects had to have adequate levels of organ function within 7 days before randomization.
- * Female subjects of childbearing potential had to undergo a urine pregnancy or serum pregnancy test with a negative result within 7 days before randomization. If the urine pregnancy test is positive or cannot be confirmed as negative, a serum pregnancy test m
- * Use of a medically approved, highly effective contraceptive method during the study and for 6 months after the last administration of study medication; Male subjects whose partner is a female of reproductive age should be surgically sterilized or agree to us
- I have signed the informed consent form and am willing and able to follow the study procedures required by the protocol.
联系前需要确认
请继续确认中心是否启动、疾病分型、既往治疗、检查费用和知情同意安排。
查看登记信息
登记号：NCT07823049；登记信息更新于 2026-09-16。